FUNDAMENTALS |
MarketCap: |
2.78 mill
|
EPS: |
-0.0100
|
P/E: |
-3.20
|
Earnings Date: |
N/A |
SharesOutstanding: |
87.10 mill
|
Avg Daily Volume: |
0.0816 mill
|
RATING
2024-05-03 |
C+
|
Sell
|
RATINGS |
Rating CashFlow: |
Strong Sell
|
|
Return On Equity: |
Strong Sell
|
|
Return On Asset: |
Strong Buy
|
|
DE: |
Strong Sell
|
|
P/E: |
Neutral
|
|
Price To Book: |
Strong Sell
|
|
QUARTER GROWTHS |
|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 |
Revenue | | | | n/a | n/a | |
Gr.Profit | | | | n/a | n/a | |
Ebit | | | | | | |
Asset | | | | | | |
Debt | | | | | | |
PE RATIO: COMPANY / SECTOR |
0.00x
|
Company: PE -3.20 | sector: PE -11.58
|
PE RATIO: COMPANY / INDUSTRY |
0x
|
Company: PE -3.20 | industry: PE -2.06
|
DISCOUNTED CASH FLOW VALUE |
$-0.0241
(-175.26%)
$-0.0560
|
Date: 2024-05-04
|
Expected Trading Range (DAY) |
$ 0.0270 - 0.0370
( +/- 15.64%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2021-10-21 | Douglass A Stone | Buy | 1 500 000 | Common Stock |
2021-07-01 | Douglass A Stone | Sell | 1 000 000 | Stock Option (Right to Buy) |
2021-07-01 | Denkin Todd | Buy | 1 500 000 | Common Stock |
2021-07-01 | Denkin Todd | Sell | 0 | Common Stock |
2021-06-25 | Hartmann Dennis | Buy | 125 000 | Common Stock |
INSIDER POWER |
0.00
|
Last
90 transactions |
Buy:
50 347 528 | Sell:
13 800 000 |
Forecast:
16:00 - $0.0320
Live Trading Signals (every 1 min)
Forecast
1: 15:44 - $0.0320
Forecast 2: 16:00 - $0.0320
Forecast 3: 16:00 - $0.0320
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
MACD |
|
Volume Signals |
Price |
$0.0320 (-2.53% )
|
Volume |
0.0020 mill
|
Avg. Vol. |
0.0816 mill
|
% of Avg. Vol |
2.39 %
|
Signal 1: |
|
Signal 2: |
|
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For DIGP
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Digipath, Inc., together with its subsidiaries, provides cannabis and hemp lab testing services in Las Vegas to Nevada licensed medical marijuana enterprises. It also provides testing, cannabis education and training, and cannabis news coverage to the cannabis industry. The company operates as a testing laboratory facility for cannabis, cannabis infused products, hemp, and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients, and end users of cannabis and botanical products. In addition, its labs screen medicinal and recreational cannabis for potentially harmful contaminants, including residual solvents; moisture; water activity; visual inspection; pesticides; heavy metals, such as mercury, arsenic, lead, cadmium, chromium, and nickel; biological toxins comprising aflatoxin and ocratoxins; and microbial contaminants consisting of E. coli, salmonella, coliforms, aspergillus, gram negative bacteria, total aerobic bacteria, and mold and yeast. Digipath, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.